IL27 and melanoma: These studies have shown that IL-27 exerts an antitumor effect on poorly immunogenic B16F10 melanoma by means of antiproliferative, antiangiogenic, Cytotoxic T lymphocyte (CTL), and NK cells activity [19, 32, 33].